Hiroyuki Ito

1.1k total citations
53 papers, 470 citations indexed

About

Hiroyuki Ito is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hiroyuki Ito has authored 53 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 26 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Hiroyuki Ito's work include Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (15 papers) and Urological Disorders and Treatments (7 papers). Hiroyuki Ito is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (15 papers) and Urological Disorders and Treatments (7 papers). Hiroyuki Ito collaborates with scholars based in Japan, Ireland and Myanmar. Hiroyuki Ito's co-authors include Chikara Οhyama, Yasuhiro Hashimoto, Takahiro Yoneyama, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Naoki Fujita, Kazuaki Yoshikawa, Shingo Hatakeyama and Toshiaki Kawaguchi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroyuki Ito

48 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroyuki Ito Japan	13	222	165	116	73	72	53	470
Christina Louise Derleth United States	11	238 1.1×	170 1.0×	290 2.5×	12 0.2×	134 1.9×	24	615
Xiaohua Zhang China	11	189 0.9×	50 0.3×	36 0.3×	44 0.6×	96 1.3×	24	331
Takuto Shimizu Japan	12	137 0.6×	96 0.6×	94 0.8×	13 0.2×	168 2.3×	56	432
Hiroyuki Tsunemori Japan	12	135 0.6×	144 0.9×	53 0.5×	84 1.2×	129 1.8×	40	420
J.L. Álvarez-Ossorio Spain	10	136 0.6×	127 0.8×	37 0.3×	70 1.0×	175 2.4×	34	419
Shuai Hu China	10	77 0.3×	123 0.7×	81 0.7×	57 0.8×	63 0.9×	18	310
M.J. Requena-Tapia Spain	12	103 0.5×	162 1.0×	50 0.4×	20 0.3×	196 2.7×	37	437
José A. Lorente Spain	8	163 0.7×	110 0.7×	49 0.4×	26 0.4×	169 2.3×	15	367
Merica Glavina Durdov Croatia	13	61 0.3×	94 0.6×	73 0.6×	30 0.4×	194 2.7×	48	420
Myrto Giannopoulou Greece	8	109 0.5×	25 0.2×	59 0.5×	34 0.5×	77 1.1×	14	324

Countries citing papers authored by Hiroyuki Ito

Since Specialization

Citations

This map shows the geographic impact of Hiroyuki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Ito more than expected).

Fields of papers citing papers by Hiroyuki Ito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Ito. The network helps show where Hiroyuki Ito may publish in the future.

Co-authorship network of co-authors of Hiroyuki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Ito. A scholar is included among the top collaborators of Hiroyuki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Ito. Hiroyuki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shintani, Yasushi, Hiroyuki Yamamoto, Yukio Sato, et al.. (2024). Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis. Surgery Today. 55(2). 265–272.

Ito, Hiroyuki, Keita Nakane, Makoto Kawase, et al.. (2024). Impact of Robotic-Assisted Partial Nephrectomy with Single Layer versus Double Layer Renorrhaphy on Postoperative Renal Function. Current Oncology. 31(5). 2758–2768. 2 indexed citations

Morimoto, Yasuhiro, Tatsuya Nagai, Hiroyuki Ito, et al.. (2024). Effectiveness of pulse methylprednisolone in patients with non-human immunodeficiency virus pneumocystis pneumonia: a multicentre, retrospective registry-based cohort study. BMC Infectious Diseases. 24(1). 1233–1233. 3 indexed citations

Morisaki, Koichi, Daisuke Matsuda, Atsushi Guntani, et al.. (2024). Comparison of Early Outcomes in Patients Who Underwent Common Femoral Thromboendarterectomy with Vein versus Bovine Pericardial Patches. Annals of Vascular Surgery. 110(Pt A). 498–504.

Fujita, Naoki, Masaki Momota, Shingo Hatakeyama, et al.. (2023). Impact of neoadjuvant chemotherapy–induced acute kidney injury on oncological outcomes in patients who underwent radical cystectomy: A multicenter retrospective study.. Journal of Clinical Oncology. 41(6_suppl). 573–573. 1 indexed citations

Ito, Hiroyuki, et al.. (2023). Surgical Treatment of Sac Enlargement Due to Type II Endoleaks Following Endovascular Aneurysm Repair. Annals of Vascular Diseases. 16(1). 1–7. 2 indexed citations

Nagai, Tatsuya, Kyoko Yoshida-Court, Toshiyuki Karumai, et al.. (2023). Left Main Bronchus Obstruction in a Patient with Small-cell Lung Cancer Successfully Treated with Venovenous Extracorporeal Membrane Oxygenation. Internal Medicine. 63(2). 293–298. 1 indexed citations

Yoshino, Ichiro, Yasumitsu Moriya, Kenji Suzuki, et al.. (2023). Long-term outcome of patients with peripheral ground-glass opacity–dominant lung cancer after sublobar resections. Journal of Thoracic and Cardiovascular Surgery. 166(4). 1222–1231.e1. 12 indexed citations

Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2023). Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer. PLoS ONE. 18(2). e0275921–e0275921. 1 indexed citations

10.

Fujita, Naoki, Masaki Momota, Itsuto Hamano, et al.. (2023). Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study. Cancers. 15(5). 1489–1489. 2 indexed citations

11.

Nakamura, Shigeru, Toshio Koike, Tomoki Ushiyama, et al.. (2022). AN OPERATION SUPPORTING SYSTEM FOR HYDROELTCTRIC DAMS: LONG AND SHORT TERM ENSEMBLE PREDICTIONS AND ITS APPLICATIONS. Journal of Japan Society of Civil Engineers Ser B1 (Hydraulic Engineering). 78(2). I_1195–I_1200.

12.

Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2022). Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high‐risk non‐muscle‐invasive bladder cancer who receive adjuvant induction bacillus Calmette‐Guérin therapy. International Journal of Urology. 29(8). 867–875. 1 indexed citations

13.

Hatakeyama, Shingo, Hideo Kawaguchi, Yoshiomi Hatayama, et al.. (2021). Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study. Urologic Oncology Seminars and Original Investigations. 40(2). 64.e1–64.e8. 11 indexed citations

14.

Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2020). Preoperative chronic kidney disease predicts poor prognosis in patients with primary non–muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor. Urologic Oncology Seminars and Original Investigations. 38(8). 684.e1–684.e8. 8 indexed citations

15.

Fujita, Naoki, Shingo Hatakeyama, Masaki Momota, et al.. (2020). Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(8). 684.e17–684.e24. 9 indexed citations

16.

Tanaka, Toshikazu, Shingo Hatakeyama, Kazuyuki Numakura, et al.. (2020). Efficacy and safety of first‐line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study. International Journal of Urology. 27(12). 1095–1100. 20 indexed citations

17.

Ishikawa, Goro, Takeshi Hayashi, Kazuhiro Nakamura, et al.. (2020). Multifamily QTL analysis and comprehensive design of genotypes for high-quality soft wheat. PLoS ONE. 15(3). e0230326–e0230326. 7 indexed citations

18.

Ito, Hiroyuki. (2012). Study on Applicability of Adjoint Method to Inundation Analysis. Journal of Japan Society of Civil Engineers Ser A2 (Applied Mechanics (AM)). 68(2). I_625–I_635.

19.

Ito, Hiroyuki, et al.. (2012). [Ultrasound-guided peripheral nerve block for high-risk patients with arteriosclerosis obliterans in lower limb surgery--a report of nine cases].. PubMed. 61(10). 1117–20. 1 indexed citations

20.

Morisaki, Koichi, et al.. (2011). Delayed closure technique for a ruptured abdominal aortic aneurysm: Report of three cases. Surgery Today. 41(7). 1003–1006. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact